# Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus Lamivudine

> **NCT01580202** · PHASE3 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 180 (actual)

## Conditions studied

- Malignancy
- Hepatitis B

## Interventions

- **DRUG:** Entecavir
- **DRUG:** Lamivudine

## Key facts

- **NCT ID:** NCT01580202
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2017-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01580202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01580202, "Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus Lamivudine". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01580202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*